to evaluate the safety , reactogenicity and immunogenicity of inactivated chromatographic influenza vaccine a ( h3n2 ) produced by the pasteur research institute of epidemiology and microbiology in leningrad , children aged 7-15 years received the vaccine intradermally in doses of 114-228 iu , and 152 children received placebo .
C0042212
inactivated
C0042210
vaccine